FTL anticorps (AA 38-165)
Aperçu rapide pour FTL anticorps (AA 38-165) (ABIN6252862)
Antigène
Voir toutes FTL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 38-165
-
Purification
- Protein G affinity chromatography
-
Immunogène
- Amino acids 38-165 of human FTL were used as the immunogen for this Ferritin Light Chain antibody.
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
-
Western blot: 0.1-0.2 μg/mL
Flow Cytometry: 0.1-0.2 μg/10^6 cells
IF: 0.1-0.2 μg/mL
IHC (FFPE): 0.1-0.2 μg/mL for 30 min at RT
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Ferritin Light Chain antibody to be titered up or down for optimal performance. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
-
- FTL (Ferritin, Light Polypeptide (FTL))
-
Autre désignation
- FTL1
-
Sujet
- Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.
-
ID gène
- 2512
-
UniProt
- P02792
-
Pathways
- Transition Metal Ion Homeostasis
Antigène
-